|
The information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.
Abbott Molecular introduced six CE-marked FISH tests in Europe to be used for identifying chromosomal abnormalities associated with acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL). Accelr8 Technology Corporation is developing its BACcelr8r platform to rapidly analyze organisms associated with ventilator-associated pneumonia (VAP) and organisms that belong in each of three major antibiotic resistance categories encountered with VAP. This includes tests for MRSA and bacterial strains that produce extended spectrum beta-lactamase enzymes. GreenChip, a glass microarray slide containing nucleotides for nearly 30,000 different viruses, bacteria, fungi and parasites can detect malaria, influenza and many other infectious diseases. The device is already being used by the World Health Organization, the U.S. Defense Department and the Centers for Disease Control and Prevention. Luminex Corporation will acquire Tm Bioscience Corporation. Tm's products include tests for infectious diseases and tests for genetic mutations related to cystic fibrosis and sepsis. Oxford Gene Technology, St. George’s University of London, and St. George’s Healthcare NHS plan to develop a single-platform microarray that could diagnose multiple sexually transmitted diseases. Quidel acquired an exclusive, worldwide license to the MChip microarray-based influenza detection technology developed by scientists at the University of Colorado in close collaboration with the U.S. CDC. Quidel’s intent is to develop and market molecular-based diagnostic tests featuring the MChip for use in pandemic surveillance, as a tool for the clinical laboratory and at the point-of-care in the physician office laboratory. Researchers at Cincinnati Children's Hospital Medical Center have developed a gene chip to use in the early diagnosis of at least five hereditary liver diseases, to detect genetic causes of jaundice in children and adults, and potentially to lead to personalized treatment options.
Product Developments Worldwide | Research News | Health Care in Canada Information Technology and Healthcare | Molecular Biology | Links
![[HRule Image]](images/div.jpg){kind=small} Send mail to stratcom@total.net with questions or comments about this web site.Concept and Design Blue Page
Productions Last modified: January 04, 2007 |
![[Page Banner Image]](images/hmole.gif){kind=small}
